How to Prepare for FDA One-Day Inspectional Assessments

The regulatory landscape is shifting. The U.S. Food and Drug Administration (FDA) has launched a pilot program for abbreviated, one-day inspections at manufacturing and other lower-risk facilities . This initiative, which began in April 2026, represents a strategic move toward more targeted, data-driven oversight . While these FDA One-Day Inspectional Assessments are designed to complement—not replace—traditional comprehensive inspections, they demand a new level of perpetual readiness.

This isn't about relaxing standards; it's about modernizing how standards are applied . A one-day visit can swiftly escalate into a full-blown inspection if investigators make significant observations . The pressure is on, and preparation is no longer a periodic event but a continuous state of operational excellence.

What Are FDA One-Day Inspectional Assessments?

The FDA's pilot is designed as a screening tool for facilities with strong compliance histories . Using risk-based criteria such as product type and prior inspection outcomes, the agency selects sites for these focused, one-day reviews . The goal is to conduct a greater number of overall inspections and use the findings to refine risk models for future oversight .

Crucially, these assessments:

• Are not a replacement: They are an additional tool in the FDA's inspection toolkit and do not change enforcement policy .

• Can be extended: Investigators retain the authority to expand the scope or duration if they identify issues, potentially converting the visit into a full investigation .

• May be unannounced: Discretion over whether a visit is announced or unannounced lies with the investigators, aligning with the FDA's broader move toward more unannounced inspections, including at foreign facilities .

• Cover multiple sectors: The pilot includes facilities involved in human and animal foods, biologics, medical products, and clinical research .

This proactive shift requires immediate action. It's time to consult experts and engage Quality Smart Solutions to ensure your quality systems are not just compliant but optimized for the rigors of a surprise assessment.

The "Always Ready" Mindset

With these one-day assessments, there is no time for last-minute document assembly or frantic preparations . The FDA's inspection philosophy is evolving toward more frequent, but more focused, oversight . This demands a shift from "inspection readiness" to perpetual readiness. Your facility must be able to demonstrate real-time operational compliance and a culture of quality every single day.

Building a Culture of Compliance

A successful inspection—whether it lasts one day or five—starts with a culture of compliance ingrained in your daily operations . This means:

• SOPs are Living Documents: Your Standard Operating Procedures (SOPs) must be accurate, clear, and actively followed. If they aren't, fix them before an investigator points out the flaw .

• Proactive Remediation: Identify and correct issues before they become observations. This includes conducting routine facility walk-throughs with an investigator's critical eye .

• Data Integrity is Paramount: Ensure all documentation adheres to strict data integrity rules (ALCOA+ principles) to build a foundation of trust and reliability .

• Training is Continuous: All employees must be thoroughly trained for their roles, with easily accessible training records. An investigator will check .

Practical Steps for Preparation

While the culture is the foundation, specific tactical steps are essential to prepare for the day an investigator arrives.

1. Form an Inspection Management Team (IMT)

Assign roles and responsibilities well in advance . Your IMT should include:

• Inspection Lead: Typically the site head of quality.

• Hosts & Scribes: To escort investigators and document every request and conversation.

• War Room Coordinator: To manage the central hub for receiving and fulfilling document requests.

• Subject Matter Experts (SMEs): The most critical members. Choose SMEs who are knowledgeable, can communicate clearly and concisely under pressure, and know how to answer questions using SOPs and data .

2. Conduct Mock Inspections

Practice is non-negotiable. Running simulated inspections—preferably unannounced—will test your team, your systems, and your logistics . A mock inspection should:

• Challenge the War Room with a high volume of document requests.

• Prepare SMEs for difficult questions and high-stress interactions.

• Help identify gaps in your document retrieval processes before a real investigator does.

Don't leave your compliance to chance. Let Quality Smart Solutions guide you through mock inspections and gap assessments to ensure you're truly ready for the FDA.

3. Ensure Rapid Document Accessibility

In a one-day assessment, time is the most critical commodity. An unreasonable delay in producing records can be interpreted as a refusal to permit an inspection .

• Go Digital: Move away from paper-based systems where possible .

• Know Your Systems: Ensure all key personnel know how to access and retrieve documents from your QMS, LIMS, and MES .

• Stage Core Documents: Keep a prepared package ready, including the Site Master File, index of procedures, and a list of U.S.-approved products .

4. Benchmark and Analyze

Knowledge is power. Review recent FDA warning letters and Form 483s to understand current trends and areas of focus . Proactively analyze your own QMS metrics to identify potential concerns before the FDA does . Look for backlogs in deviations, complaints, or investigations, and address them immediately.

The Day of the Assessment

When an investigator arrives, the tone is set. Remain calm and follow your procedures. Escort the investigator to their workspace and begin a structured process.

• Hold Daily Debriefs: At the end of each day, meet with your IMT to discuss the investigator's focus areas, address any potential observations, and prepare for the next day .

• Address Issues Proactively: If a potential concern is raised, work to correct it immediately. Document any actions taken and have the evidence ready for the investigator when they return .

• Listen and Learn: During the close-out, listen carefully to any observations. Don't argue. Instead, wait for the official Form 483 and prepare a thorough, evidence-backed response within the 15-day window .

Looking Forward

The one-day pilot, likely to continue through FY-2026, is a clear signal of the FDA's future direction . It represents a move toward AI-assisted oversight and data-driven enforcement .

For regulated entities, the message is clear: perpetual readiness is the new standard. By fostering a culture of compliance, building a robust quality system, and conducting rigorous preparation, your facility can not only survive a one-day assessment but thrive, turning regulatory scrutiny into a testament to your operational excellence. First impressions matter more now than ever . Ensure yours is one of complete, confident compliance.